Tag: metabolic disease

Drugs For Rare Diseases: How To Fund Them?

Toronto, ON, Canada– Enzyme replacement therapies for rare inherited metabolic diseases are among the most expensive drugs in the world and have created a dilemma for public drug payers.

Posted in Policy Perspectives, Value in Health Tagged with: , , , ,